Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

Contact us

• Submission enquiries: bmcmedicineeditorial@biomedcentral.com
• General enquiries: info@biomedcentral.com